Extracorporeal Membrane Oxygenation in Adult Acute Respiratory Distress Syndrome

Critical Care Clinics

Volumn 27, Issue 3, 2011, Pages 627-646

  Park, Pauline K ^a   Napolitano, Lena M ^a   Bartlett, Robert H ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

Acute respiratory distress syndrome; Extracorporeal life support; Extracorporeal membrane oxygenation; Respiratory failure

Indexed keywords

2009 H1N1 INFLUENZA; ADULT RESPIRATORY DISTRESS SYNDROME; ARTIFICIAL VENTILATION; BLEEDING; CLINICAL TRIAL; EXTRACORPOREAL OXYGENATION; FOLLOW UP; HEALTH CARE COST; HEART SURGERY; HEMOLYSIS; HUMAN; INTENSIVE CARE UNIT; LONG TERM CARE; LUNG INSUFFICIENCY; MORTALITY; PRIORITY JOURNAL; REVIEW; SEPSIS;

EXTRACORPOREAL MEMBRANE OXYGENATION; HUMANS; LIFE SUPPORT CARE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESPIRATORY DISTRESS SYNDROME, ADULT; RESPIRATORY INSUFFICIENCY; TRANSPORTATION OF PATIENTS;

EID: 79960132882     PISSN: 07490704     EISSN: 15578232     Source Type: Journal    
DOI: 10.1016/j.ccc.2011.05.009     Document Type: Review

References (108)

1. Dominguez-Cherit G., Lapinsky S.E., Macias A.E., et al. Critically ill patients with 2009 influenza A(H1N1) in Mexico. JAMA 2009, 302(17):1880-1887.
2. Carrell S. Pregnant woman with swine flu airlifted to Sweden 2009, The Guardian, London (UK), Accessed April 30, 2011.
3. Mitchell M.D., Mikkelsen M.E., Umscheid C.A., et al. A systematic review to inform institutional decisions about the use of extracorporeal membrane oxygenation during the H1N1 influenza pandemic. Crit Care Med 2010, 38(6):1398-1404.
4. Chalwin R.P., Moran J.L., Graham P.L. The role of extracorporeal membrane oxygenation for treatment of the adult respiratory distress syndrome: review and quantitative analysis. Anaesth Intensive Care 2008, 36(2):152-161.
5. Allen S., Holena D., McCunn M., et al. A review of the fundamental principles and evidence base in the use of extracorporeal membrane oxygenation (ECMO) in critically ill adult patients. J Intensive Care Med 2011, 26(1):13-26.
6. Combes A. EOLIA (Extracorporeal membrane oxygenation (ECMO) to rescue Lung Injury in severe ARDS) Available at:, Accessed May 2, 2011. http://reaweb.org/gb/etudes.php%23e2.
7. van Muers K., Lally K., Peek G., et al. ECMO. Extracorporeal cardiopulmonary support in critical care 2005, Extracorporeal Life Support Organization (ELSO), Ann Arbor (MI). 3rd edition.
8. Zapol W.M., Snider M.T., Hill J.D., et al. Extracorporeal membrane oxygenation in severe acute respiratory failure. A randomized prospective study. JAMA 1979, 242(20):2193-2196.
9. Morris A.H., Wallace C.J., Menlove R.L., et al. Randomized clinical trial of pressure-controlled inverse ratio ventilation and extracorporeal CO2 removal for adult respiratory distress syndrome. Am J Respir Crit Care Med 1994, 149(2 Pt 1):295-305.
10. Peek G.J., Mugford M., Tiruvoipati R., et al. Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial. Lancet 2009, 374(9698):1351-1363.
11. Mols G., Loop T., Geiger K., et al. Extracorporeal membrane oxygenation: a ten-year experience. Am J Surg 2000, 180(2):144-154.
12. Lewandowski K., Rossaint R., Pappert D., et al. High survival rate in 122 ARDS patients managed according to a clinical algorithm including extracorporeal membrane oxygenation. Intensive Care Med 1997, 23(8):819-835.
13. Beiderlinden M., Eikermann M., Boes T., et al. Treatment of severe acute respiratory distress syndrome: role of extracorporeal gas exchange. Intensive Care Med 2006, 32(10):1627-1631.
14. Hill J.D., De Leval M.R., Fallat R.J., et al. Acute respiratory insufficiency. Treatment with prolonged extracorporeal oxygenation. J Thorac Cardiovasc Surg 1972, 64(4):551-562.
15. Bartlett R.H., Morris A.H., Fairley H.B., et al. A prospective study of acute hypoxic respiratory failure. Chest 1986, 89(5):684-689.
16. Gattinoni L., Pesenti A., Mascheroni D., et al. Low-frequency positive-pressure ventilation with extracorporeal CO2 removal in severe acute respiratory failure. JAMA 1986, 256(7):881-886.
17. Suchyta M.R., Clemmer T.P., Orme J.F., et al. Increased survival of ARDS patients with severe hypoxemia (ECMO criteria). Chest 1991, 99(4):951-955.
18. UK collaborative randomised trial of neonatal extracorporeal membrane oxygenation. UK Collaborative ECMO Trail Group. Lancet 1996, 348(9020):75-82.
19. Zwischenberger J.B., Lynch J.E. Will CESAR answer the adult ECMO debate?. Lancet 2009, 374(9698):1307-1308.
20. Nehra D., Goldstein A.M., Doody D.P., et al. Extracorporeal membrane oxygenation for nonneonatal acute respiratory failure: the Massachusetts General Hospital experience from 1990 to 2008. Arch Surg 2009, 144(5):427-432. [discussion: 432].
21. Hemmila M.R., Rowe S.A., Boules T.N., et al. Extracorporeal life support for severe acute respiratory distress syndrome in adults. Ann Surg 2004, 240(4):595-605. [discussion: 605-7].
22. Buckley E., Sidebotham D., McGeorge A., et al. Extracorporeal membrane oxygenation for cardiorespiratory failure in four patients with pandemic H1N1 2009 influenza virus and secondary bacterial infection. Br J Anaesth 2010, 104(3):326-329.
23. Freed D.H., Henzler D., White C.W., et al. Extracorporeal lung support for patients who had severe respiratory failure secondary to influenza A (H1N1) 2009 infection in Canada. Can J Anaesth 2010, 57(3):240-247.
24. Grasselli G., Foti G., Patroniti N., et al. A case of ARDS associated with influenza A - H1N1 infection treated with extracorporeal respiratory support. Minerva Anestesiol 2009, 75(12):741-745.
25. Liong T., Lee K.L., Poon Y.S., et al. The first novel influenza A (H1N1) fatality despite antiviral treatment and extracorporeal membrane oxygenation in Hong Kong. Hong Kong Med J 2009, 15(5):381-384.
26. Kao T.M., Wang C.H., Chen Y.C., et al. The first case of severe novel H1N1 influenza successfully rescued by extracorporeal membrane oxygenation in Taiwan. J Formos Med Assoc 2009, 108(11):894-898.
27. Brogan T.V., Thiagarajan R.R., Rycus P.T., et al. Extracorporeal membrane oxygenation in adults with severe respiratory failure: a multi-center database. Intensive Care Med 2009, 35(12):2105-2114.
28. Davies A., Jones D., Bailey M., et al. Extracorporeal membrane oxygenation for 2009 influenza A(H1N1) acute respiratory distress syndrome. JAMA 2009, 302(17):1888-1895.
29. Davies A., Jones D., Gattas D., et al. Extracorporeal membrane oxygenation for ARDS due to 2009 influenza A (H1N1). JAMA 2010, 303(10):942. for the ANZ-ECMO Investigators, [reply].
30. Campbell B.T., Braun T.M., Schumacher R.E., et al. Impact of ECMO on neonatal mortality in Michigan (1980-1999). J Pediatr Surg 2003, 38(3):290-295. [discussion: 290-5].
31. Green T.P., Timmons O.D., Fackler J.C., et al. The impact of extracorporeal membrane oxygenation on survival in pediatric patients with acute respiratory failure. Pediatric Critical Care Study Group. Crit Care Med 1996, 24(2):323-329.
32. Murray J.F., Matthay M.A., Luce J.M., et al. An expanded definition of the adult respiratory distress syndrome. Am Rev Respir Dis 1988, 138(3):720-723.
33. Arlt M., Philipp A., Voelkel S., et al. Hand-held minimised extracorporeal membrane oxygenation: a new bridge to recovery in patients with out-of-centre cardiogenic shock. Eur J Cardiothorac Surg 2011, [Epub ahead of print].
34. Philipp A., Arlt M., Amann M., et al. First experience with the ultra compact mobile extracorporeal membrane oxygenation system Cardiohelp in interhospital transport. Interact Cardiovasc Thorac Surg 2011, [Epub ahead of print].
35. Wang D., Zhou X., Liu X., et al. Wang-Zwische double lumen cannula-toward a percutaneous and ambulatory paracorporeal artificial lung. ASAIO J 2008, 54(6):606-611.
36. Toomasian J.M., Bartlett R.H. Hemolysis and ECMO pumps in the 21st century. Perfusion 2011, 26(1):5-6.
37. Zhang J., Gellman B., Koert A., et al. Computational and experimental evaluation of the fluid dynamics and hemocompatibility of the CentriMag blood pump. Artif Organs 2006, 30(3):168-177.
38. Thiara A.P., Hoel T.N., Kristiansen F., et al. Evaluation of oxygenators and centrifugal pumps for long-term pediatric extracorporeal membrane oxygenation. Perfusion 2007, 22(5):323-326.
39. Kolobow T., Zapol W., Pierce J.E., et al. Partial extracorporeal gas exchange in alert newborn lambs with a membrane artificial lung perfused via an A-V shunt for periods up to 96 hours. Trans Am Soc Artif Intern Organs 1968, 14:328-334.
40. Lehle K., Philipp A., Gleich O., et al. Efficiency in extracorporeal membrane oxygenation-cellular deposits on polymethylpentene membranes increase resistance to blood flow and reduce gas exchange capacity. ASAIO J 2008, 54(6):612-617.
41. Peek G.J., Killer H.M., Reeves R., et al. Early experience with a polymethyl pentene oxygenator for adult extracorporeal life support. ASAIO J 2002, 48(5):480-482.
42. Horton S., Thuys C., Bennett M., et al. Experience with the Jostra Rotaflow and QuadroxD oxygenator for ECMO. Perfusion 2004, 19(1):17-23.
43. Bindslev L. Adult ECMO performed with surface-heparinized equipment. ASAIO Trans 1988, 34(4):1009-1013.
44. Moen O., Hogasen K., Fosse E., et al. Attenuation of changes in leukocyte surface markers and complement activation with heparin-coated cardiopulmonary bypass. Ann Thorac Surg 1997, 63(1):105-111.
45. Fosse E., Moen O., Johnson E., et al. Reduced complement and granulocyte activation with heparin-coated cardiopulmonary bypass. Ann Thorac Surg 1994, 58(2):472-477.
46. Meinhardt J.P., Annich G.M., Miskulin J., et al. Thrombogenicity is not reduced when heparin and phospholipid bonded circuits are used in a rabbit model of extracorporeal circulation. ASAIO J 2003, 49(4):395-400.
47. Lawson D.S., Lawson A.F., Walczak R., et al. North American neonatal extracorporeal membrane oxygenation (ECMO) devices and team roles: 2008 survey results of Extracorporeal Life Support Organization (ELSO) centers. J Extra Corpor Technol 2008, 40(3):166-174.
48. Bare J.B., Abramowsky C.R., Denton T.D., et al. Perforation of the superior vena cava during ECMO catheterization in two neonates with congenital diaphragmatic hernia: a cause of accidental death. Am J Forensic Med Pathol 2008, 29(3):271-273.
49. Ruettimann U., Ummenhofer W., Rueter F., et al. Management of acute respiratory distress syndrome using pumpless extracorporeal lung assist. Can J Anaesth 2006, 53(1):101-105.
50. Reng M., Philipp A., Kaiser M., et al. Pumpless extracorporeal lung assist and adult respiratory distress syndrome. Lancet 2000, 356(9225):219-220.
51. Zimmermann M., Bein T., Arlt M., et al. Pumpless extracorporeal interventional lung assist in patients with acute respiratory distress syndrome: a prospective pilot study. Crit Care 2009, 13(1):R10.
52. Habashi N.M., Borg U.R., Reynolds H.N. Low blood flow extracorporeal carbon dioxide removal (ECCO2R): a review of the concept and a case report. Intensive Care Med 1995, 21(7):594-597.
53. Terragni P.P., Del Sorbo L., Mascia L., et al. Tidal volume lower than 6 ml/kg enhances lung protection: role of extracorporeal carbon dioxide removal. Anesthesiology 2009, 111(4):826-835.
54. Terragni P.P., Birocco A., Faggiano C., et al. Extracorporeal CO2 removal. Contrib Nephrol 2010, 165:185-196.
55. Clement K.C., Fiser R.T., Fiser W.P., et al. Single-institution experience with interhospital extracorporeal membrane oxygenation transport: a descriptive study. Pediatr Crit Care Med 2010, 11(4):509-513.
56. Linden V., Palmer K., Reinhard J., et al. Inter-hospital transportation of patients with severe acute respiratory failure on extracorporeal membrane oxygenation-national and international experience. Intensive Care Med 2001, 27(10):1643-1648.
57. Coppola C.P., Tyree M., Larry K., et al. A 22-year experience in global transport extracorporeal membrane oxygenation. J Pediatr Surg 2008, 43(1):46-52. [discussion: 52].
58. Forrest P., Ratchford J., Burns B., et al. Retrieval of critically ill adults using extracorporeal membrane oxygenation: an Australian experience. Intensive Care Med 2011, 37(5):824-830.
59. Zimmermann M., Bein T., Philipp A., et al. Interhospital transportation of patients with severe lung failure on pumpless extracorporeal lung assist. Br J Anaesth 2006, 96(1):63-66.
60. Zimmermann M., Philipp A., Schmid F.X., et al. From Baghdad to Germany: use of a new pumpless extracorporeal lung assist system in two severely injured US soldiers. ASAIO J 2007, 53(3):e4-e6.
61. Bein T., Osborn E., Hofmann H.S., et al. Successful treatment of a severely injured soldier from Afghanistan with pumpless extracorporeal lung assist and neurally adjusted ventilatory support. Int J Emerg Med 2010, 3(3):177-179.
62. Robbins S. A breath of life: U.S. medical team uses new method to save soldier's life 2010, Stars and Stripes, Washington, DC.
63. Dorlac G.R., Fang R., Pruitt V.M., et al. Air transport of patients with severe lung injury: development and utilization of the acute lung rescue team. J Trauma 2009, 66(Suppl 4):S164-S171.
64. Underwood M.J., Pearson J.A., Waggoner J., et al. Changes in "inflammatory" mediators and total body water during extra-corporeal membrane oxygenation (ECMO). A preliminary study. Int J Artif Organs 1995, 18(10):627-632.
65. Halter J., Steinberg J., Fink G., et al. Evidence of systemic cytokine release in patients undergoing cardiopulmonary bypass. J Extra Corpor Technol 2005, 37(3):272-277.
66. McILwain R.B., Timpa J.G., Kurundkar A.R., et al. Plasma concentrations of inflammatory cytokines rise rapidly during ECMO-related SIRS due to the release of preformed stores in the intestine. Lab Invest 2010, 90(1):128-139.
67. McCoy-Pardington D., Judd W.J., Knafl P., et al. Blood use during extracorporeal membrane oxygenation. Transfusion 1990, 30(4):307-309.
68. Butch S.H., Knafl P., Oberman H.A., et al. Blood utilization in adult patients undergoing extracorporeal membrane oxygenated therapy. Transfusion 1996, 36(1):61-63.
69. Cooling L., Park P.K., Napolitano L. Blood transfusion support in critically ill H1N1 patients. Transfusion 2010, 50S:27A-28A.
70. Noerr B. ECMO and pharmacotherapy. Neonatal Netw 1996, 15(6):23-31.
71. Dagan O., Klein J., Gruenwald C., et al. Preliminary studies of the effects of extracorporeal membrane oxygenator on the disposition of common pediatric drugs. Ther Drug Monit 1993, 15(4):263-266.
72. Wildschut E.D., Ahsman M.J., Allegaert K., et al. Determinants of drug absorption in different ECMO circuits. Intensive Care Med 2010, 36(12):2109-2116.
73. Arnold J.H., Truog R.D., Orav E.J., et al. Tolerance and dependence in neonates sedated with fentanyl during extracorporeal membrane oxygenation. Anesthesiology 1990, 73(6):1136-1140.
74. Dagan O., Klein J., Bohn D., et al. Effects of extracorporeal membrane oxygenation on morphine pharmacokinetics in infants. Crit Care Med 1994, 22(7):1099-1101.
75. Ahsman M.J., Hanekamp M., Wildschut E.D., et al. Population pharmacokinetics of midazolam and its metabolites during venoarterial extracorporeal membrane oxygenation in neonates. Clin Pharmacokinet 2010, 49(6):407-419.
76. Wildschut E.D., Hanekamp M.N., Vet N.J., et al. Feasibility of sedation and analgesia interruption following cannulation in neonates on extracorporeal membrane oxygenation. Intensive Care Med 2010, 36(9):1587-1591.
77. Bhatt-Mehta V., Johnson C.E., Schumacher R.E. Gentamicin pharmacokinetics in term neonates receiving extracorporeal membrane oxygenation. Pharmacotherapy 1992, 12(1):28-32.
78. Buck M.L. Pharmacokinetic changes during extracorporeal membrane oxygenation: implications for drug therapy of neonates. Clin Pharmacokinet 2003, 42(5):403-417.
79. Ahsman M.J., Wildschut E.D., Tibboel D., et al. Pharmacokinetics of cefotaxime and desacetylcefotaxime in infants during extracorporeal membrane oxygenation. Antimicrob Agents Chemother 2010, 54(5):1734-1741.
80. Wildschut E.D., de Hoog M., Ahsman M.J., et al. Plasma concentrations of oseltamivir and oseltamivir carboxylate in critically ill children on extracorporeal membrane oxygenation support. PLoS One 2010, 5(6):e10938.
81. Eyler RF, Pleva M, Sowinski KM, et al. Oseltamivir & oseltamivir carboxylate pharmacokinetics in critically ill patients receiving continuous venovenous hemodialysis (CVVHD). Paper presented at: 50th Interscience Conference on Antimicrobial Agents and Chemotherapy. Boston, September 15, 2011.
82. Ariano R.E., Sitar D.S., Zelenitsky S.A., et al. Enteric absorption and pharmacokinetics of oseltamivir in critically ill patients with pandemic (H1N1) influenza. CMAJ 2010, 182(4):357-363.
83. Oliver W.C. Anticoagulation and coagulation management for ECMO. Semin Cardiothorac Vasc Anesth 2009, 13(3):154-175.
84. Muensterer O.J., Laney D., Georgeson K.E. Survival time of ECMO circuits on and off bleeding protocol: is there a higher risk of circuit clotting?. Eur J Pediatr Surg 2011, 21(1):30-32.
85. Marasco S.F., Preovolos A., Lim K., et al. Thoracotomy in adults while on ECMO is associated with uncontrollable bleeding. Perfusion 2007, 22(1):23-26.
86. Kasirajan V., Smedira N.G., McCarthy J.F., et al. Risk factors for intracranial hemorrhage in adults on extracorporeal membrane oxygenation. Eur J Cardiothorac Surg 1999, 15(4):508-514.
87. Rao A.S., Pellegrini R.V., Speziali G., et al. A novel percutaneous solution to limb ischemia due to arterial occlusion from a femoral artery ECMO cannula. J Endovasc Ther 2010, 17(1):51-54.
88. Nankervis C.A., Preston T.J., Dysart K.C., et al. Assessing heparin dosing in neonates on venoarterial extracorporeal membrane oxygenation. ASAIO J 2007, 53(1):111-114.
89. Baird C.W., Zurakowski D., Robinson B., et al. Anticoagulation and pediatric extracorporeal membrane oxygenation: impact of activated clotting time and heparin dose on survival. Ann Thorac Surg 2007, 83(3):912-919. [discussion: 919-20].
90. Horwitz J.R., Cofer B.R., Warner B.W., et al. A multicenter trial of 6-aminocaproic acid (Amicar) in the prevention of bleeding in infants on ECMO. J Pediatr Surg 1998, 33(11):1610-1613.
91. Wilson J.M., Bower L.K., Fackler J.C., et al. Aminocaproic acid decreases the incidence of intracranial hemorrhage and other hemorrhagic complications of ECMO. J Pediatr Surg 1993, 28(4):536-540. [discussion: 540-1].
92. Available at: Accessed May 1, 2011. http://clinicaltrials.gov/ct2/show/NCT00968565.
93. Elerian L.F., Sparks J.W., Meyer T.A., et al. Usefulness of surveillance cultures in neonatal extracorporeal membrane oxygenation. ASAIO J 2001, 47(3):220-223.
94. Steiner C.K., Stewart D.L., Bond S.J., et al. Predictors of acquiring a nosocomial bloodstream infection on extracorporeal membrane oxygenation. J Pediatr Surg 2001, 36(3):487-492.
95. Burket J.S., Bartlett R.H., Vander Hyde K., et al. Nosocomial infections in adult patients undergoing extracorporeal membrane oxygenation. Clin Infect Dis 1999, 28(4):828-833.
96. Muller T., Lubnow M., Phillipp A., et al. Risk of circuit infection in septic patients on extracorporeal membrane oxygenation: a preliminary study. Artif Organs 2011, 35(4):E84-E90.
97. Petrou S., Bischof M., Bennett C., et al. Cost-effectiveness of neonatal extracorporeal membrane oxygenation based on 7-year results from the United Kingdom Collaborative ECMO Trial. Pediatrics 2006, 117(5):1640-1649.
98. Herridge M.S., Tansey C.M., Matte A., et al. Functional disability 5 years after acute respiratory distress syndrome. N Engl J Med 2011, 364(14):1293-1304.
99. Jen H.C., Shew S.B. Hospital readmissions and survival after nonneonatal pediatric ECMO. Pediatrics 2010, 125(6):1217-1223.
100. Linden V.B., Lidegran M.K., Frisen G., et al. ECMO in ARDS: a long-term follow-up study regarding pulmonary morphology and function and health-related quality of life. Acta Anaesthesiol Scand 2009, 53(4):489-495.
101. Morris A.H., Hirshberg E., Miller R.R., et al. Efficacy of ECMO in H1N1 influenza: sufficient evidence?. Chest 2010, 138(4):778-781.
102. Park P.K., Dalton H.J., Bartlett R.H. Point: efficacy of extracorporeal membrane oxygenation in 2009 influenza A(H1N1): sufficient evidence?. Chest 2010, 138(4):776-778.
103. White D.B., Angus D.C. Preparing for the sickest patients with 2009 influenza A(H1N1). JAMA 2009, 302(17):1905-1906.
104. Dalton H.J., MacLaren G. Extracorporeal membrane oxygenation in pandemic flu: insufficient evidence or worth the effort?. Crit Care Med 2010, 38(6):1484-1485.
105. Finney S.J., Cordingley J.J., Griffiths M.J., et al. ECMO in adults for severe respiratory failure finally comes of age: just in time?. Thorax 2010, 65(3):194-195.
106. Kumar A., Zarychanski R., Pinto R., et al. Critically ill patients with 2009 influenza A(H1N1) infection in Canada. JAMA 2009, 302(17):1872-1879.
107. Miller R.R., Markewitz B.A., Rolfs R.T., et al. Clinical findings and demographic factors associated with ICU admission in Utah due to novel 2009 influenza A(H1N1) infection. Chest 2010, 137(4):752-758.
108. Extracorporeal Life Support Organization Patient Specific Guidelines. A supplement to the ELSO General Guidelines (April 2009) Version 1.1 ELSO, Available at:, Accessed May 1, 2011. http://www.elso.med.umich.edu/Guidelines.html.